By defining the functional defect in a congenital myasthenic syndrome (CMS)
, we show that the third transmembrane domain (M3) of the muscle acetylchol
ine receptor governs the speed and efficiency of gating of its channel. The
clinical phenotype of this CMS results from the mutation V285I in M3 of th
e alpha subunit, which attenuates endplate currents, accelerates their deca
y and causes abnormally brief acetylcholine-induced single-channel currents
. Kinetic analysis of engineered alpha V285I receptors demonstrated a predo
minant effect on channel gating, with abnormally slow opening and rapid clo
sing rates. Analysis of site-directed mutations revealed stereochemical and
volume-dependent contributions of alpha V285 to channel gating. Thus, we d
emonstrate a functional role for the M3 domain as a key component of the ni
cotinic acetylcholine receptor channel-gating mechanism.